Bethany Ison

Ms. Bethany Ison

University of Kentucky, Lexington, Kentucky, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2022 in NeuroSci
Verified
Journal Article
Open access
PDF file
BIBethany Ison
Bethany Ison
MAMaya O. Abul-Khoudoud
Maya O. Abul-Khoudoud
SASufia Ahmed
Sufia Ahmed
AAAbraham W. Alhamdani
Abraham W. Alhamdani
CAClair Ashley
Clair Ashley
Robin CooperRobin Cooper
Robin Cooper
The resting membrane potential enables neurons to rapidly initiate and conduct electrical signals. K2p channels are key in maintaining this membrane potential and electrical excitability. They direct the resting membrane potential toward the K+ equilibrium potential. Doxapram is a known blocker for a subset of K2p channels that are pH sensitive. We assessed the effects of 0.1 and 5 mM doxapram on the neural activity within the propodite-dactylopodite (PD) proprioceptive sensory organ in the walking legs of blue crabs (Callinectes sapidus). Results indicate that 0.1 mM doxapram enhances excitation, while the higher concentration 5 mM may over-excite the neurons and promote a sustained absolute refractory period until the compound is removed. The effect of 5 mM doxapram mimics the effect of 40 mM K+ exposure. Verapamil, another known K2p channel blocker as well as an L-type Ca2+ channel blocker, reduces neural activity at both 0.1 and 5 mM. Verapamil may block stretch activated channels in sensory endings, in addition to reducing the amplitude of the compound action potential with whole nerve preparations. These findings are notable as they demonstrate that doxapram has acute effects on neurons of crustaceans, suggesting a targeted K2p channel. The actions of verapamil are complex due to the potential of affecting multiple ion channels in this preparation. Crustacean neurons can aid in understanding the mechanisms of action of various pharmacological agents as more information is gained.

30 October 2023 in Animal Behaviour
Verified
Journal Article
Closed access
RWRebecca R. Westwick
Rebecca R. Westwick
GBGavin P. Brackett
Gavin P. Brackett
CBCameron E. Brown
Cameron E. Brown
BIBethany Ison
Bethany Ison
CRClare C. Rittschof
Clare C. Rittschof

27 January 2023 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
MWMikaela L. Wagers
Mikaela L. Wagers
ASAshley Starks
Ashley Starks
MAMaya O. Abul-Khoudoud
Maya O. Abul-Khoudoud
SASufia M. Ahmed
Sufia M. Ahmed
AAAbraham W. Alhamdani
Abraham W. Alhamdani
Robin CooperRobin Cooper
Robin Cooper